charles dadswell  illumina  inc  zoominfocom charles dadswell svp and general counsel  management team     sign in contact us select country areas of interest techniques systems products  services informatics science  education company support   about us careers news center investor information contact us legal events video hub partner programs ihope doing business with illumina overview management team fact sheet corporate citizenship more questions about us management team charles dadswell management team management team charles dadswell senior vice president  general counsel charles chuck dadswell is senior vice president and general counsel of illumina where he has worldwide responsibility for all legal and intellectual property matters and is also illuminas code of ethics compliance officer before joining illumina dadswell was vice president general counsel for north and latin america and corporate director of global intellectual property at biomerieux he was previously general counsel of biodelivery sciences international a specialty pharmaceutical company and oversaw us intellectual property in a variety of positions with glaxo glaxowellcome and glaxosmithkline dadswell received an llm in patent law and trade regulation from the george washington university law school a jd from thomas m cooley law school and a bs in pharmacy from ferris state university  prev  next      management team fact sheet   bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version charles dadswells phone number email address  spokeo contact us  sponsored topics see a problem let us know legal help paired ends charles dadswell  genomeweb skip to main content rss feeds twitter linkedin log in join now business  policybusiness news research funding policy  legislation regulatory news reimbursement technologymicroarrays  multiplexing pcr informatics sequencing mass spec sample prep gene silencinggene editing researchgenetic research gene expression research epigenetics research proteomics  protein research cell biology research diagnosticsmolecular diagnostics companion diagnostics biomarker discovery  validation drug discovery  development clinical sequencing clinical proteomics disease areascancer infectious disease cardiovascular disease neurological  psychological disease metabolic disease autoimmune disease inherited disease reproductive health applied markets resourceswebinars white papers the scan career blog job listings new products people in the news conferences  events main menu enter your keywords home » paired ends charles dadswell paired ends charles dadswell apr   premium illumina has named charles dadswell senior vice president and general counsel replacing christian cabou who has retired dadswell will be responsible for all legal and intellectual property matters and will also serve as secretary to illuminas board of directors he joins illumina from biomérieux where he served as vice president and general counsel for north and latin america and corporate director of global intellectual property get the full story with genomeweb premium only  for the first  days a trial upgrade to genomeweb premium gives you full site access interestbased email alerts access to archives and more never miss another important industry story try genomeweb premium now already a genomeweb premium member login now or see if your institution qualifies for premium access before your trial expires we’ll put together a custom quote with your longterm premium options not ready for premium register for free content you can still register for access to our free content breaking news fluidigm ascendas genomics ink mdx development pact in china cancer dependency maps developed by two research teams errorprone dna repair implicated in analysis of cancer mutation signature clusters ancient genome sequences point to canaanite ancestry in presentday lebanese population qiagen q revenues grow  percent firm nudges up fullyear guidance biomatrica gets ceivd marks for sample collection tubes the scan embryos edited in us technology review reports that researchers in the us have used crispr to modify a number of human embryos true blue by introducing genes from butterfly peas and canterbury bells researchers in japan have developed a blue chrysanthemum according to npr all the plants plant researchers plan to sequence some  samples that represent the major plant clades scienceinsider reports this week in nature in nature this week a danish reference genome and more featured white papers by seracare seraseq ctdna a breakthrough qc technology by seracare  tools for overcoming your clinical lab’s toughest quality control challenges whats popular in clinical sequencing helix launches genomics marketplace hoping to entice consumers to repeatedly query dna quest joins growing market for expanded carrier screeningpremium stanford team launches sensomics in china for early autism diagnosticspremium sponsorships about us advertise contact jobs subscribe privacy policy  copyright   genomeweb llc  all rights reserved ﻿ reasons for charles dadswell’s shares unload of illumina inc nasdaqilmn’s stock – octafinance friday  july  menu featured news  years ago  alphabet inc nasdaqgoogl tests its ad technology on billboards to cushion itself against ad blocks  years ago  china margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisis  years ago  marc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and gold  years ago  carl icahn criticizes the fed feels bad for investors buying junk bonds  years ago  john burbank european qe can’t save the markets same as the us quantitative easing everything will be liquidated reasons for charles dadswell’s shares unload of illumina inc nasdaqilmn’s stock  by octastaff in blue chips insider news share with your friendsyour nameyour emailrecipient emailenter a messagei read this article and found it very interesting thought it might be interesting for you the article is called reasons for charles dadswell’s shares unload of illumina inc nasdaqilmn’s stock and is was published by octafinancecom at httpwwwoctafinancecomreasonsforcharlesdadswellssharesunloadofilluminaincnasdaqilmnsstockcaptchasubmit charles dadswell insider sell transaction mr charles dadswell the present sr vp  general counsel at illumina inc nasdaqilmn    has not a long ago been connected with an open market trade of  shares of the listed illumina inc valued at  per share the total stocks unloaded with a value of of  us dollars in the last month he also sold  shares worth approximately  usd charles dadswell now has in hand  of the company’s stock market cap with ownership of  shares  illumina inc stock rating sentiment and fundamentals and his view is not unjustified – twenty six top equity analysts covering illumina inc believe that the earningspershare will be  in  giving it a price to earnings ratio of  and a growth rate yoy not better than  additionally the market agrees with his sell according to the innovative company psychsignal the sentiment index is  rating  sentimentpsychsignal socialsellanalysts ratingbuyhedge funds sentimentbuy stock fundamentalsearnings  fcf trendbuysectorindustry macrobullishvaluation models technical analysisst trenddownmt trenddownlt trendup octafinance ratingsell  read how our stock ratings system works our analysts rate illumina inc “sell” not just because of charles dadswell’s informed stock sell but also because our time momentum model says so illumina inc’s stock chart indicates it has decreased  in the last  days and the steady and strong down trend is expected to continue price chart of illumina nasdaqilmn stock source rightedgesystems yahoo split  dividend adjusted data and octafinance interpretations hedge funds ownership data gathered from sec f filings show that  hedge funds and institutional investors have shares of illumina inc the institutional ownership of the company’s stock in q  is extremely high at  of the shares outstanding they decreased by  million the total shares they hold as of that quarter these investment managers owned  million shares a total of  funds closed their positions in illumina inc and  reduced their holdings there were  funds that created new positions and  funds that added to their positions  hedge funds are super bullish the stock and have it in their top  they are rosenblum silverman sutton s f inc ca viking global investors lp wellington shields  co llc bender robert  associates duquesne family office llc baillie gifford  co bennett lawrence management l l c ny cookson peirce  co inc cubist systematic strategies llc de burlo group inc rosenblum silverman sutton s f inc ca is the most positive institutional investor on illumina inc with ownership of  shares as of q  for  of the fund’s portfolio andreas halvorsen’s viking global investors lp is another positive institutional investor having  million shares of the company or  of their stocks portfolio the stock is also  of the fund’s aum moreover wellington shields  co llc have  of their stock portfolio invested in the stock for  shares the californiabased fund bender robert  associates revealed it had acquired a stake worth  of the fund’s stock portfolio in illumina inc stanley druckenmiller’s duquesne family office llc is also very upbeat about the californiabased company with ownership of  shares or  of their stock portfolio illumina nasdaqilmn company profile illumina inc illumina is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function the company is organized in two business segments life sciences and diagnostics its life sciences business unit includes all products and services related to the research market namely the product lines based on its sequencing beadarray veracode and realtime pcr technologies its diagnostics business unit focuses on molecular diagnostics its customers include genomic research centers academic institutions government laboratories and clinical research organizations as well as pharmaceutical biotechnology agrigenomics and consumer genomics companies in july  the company acquired myraqa a regulatory and quality consulting firm specializing in ivds particularly companion diagnostics illumina inc has  employees currently its market cap is  billion and it has  million shares outstanding currently there are  shareholders and the institutional ownership is  illumina inc was incorporated in delaware on  the stock closed at  yesterday and it had average  days volume of  shares it is up from the  days average shares volume of  illumina inc has a w low of  and a weeks high of  the stock price is above the  days simple moving average illumina inc last issued its quarterly earnings report on  the company reported  eps for the quarter above the consensus estimate of  by  the company had a revenue of  million for  and  million for  therefore the revenue was  million up  the sale was made pursuant to a b plan receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with marketbeatcoms free daily email newsletter tagged charles dadswellillumina  nasdaqilmn illumina inc nasdaqilmn’s director blaine bowman unloaded  shares of the company ben plummer unloaded  worth of datawatch corporation nasdaqdwch stock free email newsletter enter your email address below to get the latest news and analysts ratings for your stocks with our free daily email newsletter hedge fund newstop  citadel advisors f holdings in q df dent  co inc just released its q  stock positionsmaverick capital top  holdings in q analyzing ken griffins citadel advisors stock holdings in q lone pine capital top  f positions in q guru newsfelix zulauf sees a stock market correction coming this rally sp  indexspinx will be shortlivedmarc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and goldjim grant the next thing might be helicopter money what to buy and where he sees investment opportunitieskyle bass bearish on emerging markets for at least  more years looking to short currenciesdavid tepper gets defensive is it time to get out of the stock market macro newschina margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisisare us – russian relations a zerosum gameus and russia have launched direct talks on the conflict in syriayuan drops as pboc cuts reference rate by most since devaluationcould the market crash like —put volume spike argues low is nearctas newsred rock just published report about the trend following landscape  how ctas’ performance must be analyzedhow to implement dual momentum for nonus investorsdo commodity trading advisors ctas really provide crisis alpha equity hedge and are long volatility